Location History:
- Cheshire, GB (2018)
- Essex, GB (2011 - 2022)
Company Filing History:
5 out of 987 
5 out of 1,209 
2 out of 8,734 Years Active: 2011-2022
Title: James Peter Gregson: Innovator in Antibody Research
Introduction
James Peter Gregson is a notable inventor based in Essex, GB. He has made significant contributions to the field of antibody research, holding a total of 8 patents. His work focuses on developing novel human antibodies that have the potential to transform treatment options for various medical conditions.
Latest Patents
One of his latest patents is titled "Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor." This invention is based on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. The invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-L1, and/or PD-L2 activity. These conditions include persistent infectious diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders, and tumors. The innovative antibodies described in this patent offer promising avenues for therapeutic interventions.
Career Highlights
Throughout his career, James Peter Gregson has worked with prestigious institutions, including Emory University and Dana-Farber Cancer Institute Inc. His research has significantly advanced the understanding of immune modulation and its applications in treating complex diseases.
Collaborations
James has collaborated with esteemed colleagues such as Francis J Carr and Timothy David Jones. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapeutic solutions.
Conclusion
James Peter Gregson's contributions to antibody research exemplify the impact of innovation in medicine. His patents and collaborations continue to pave the way for advancements in the treatment of various diseases.